Holen Sie sich die Stockscreener-App
0.5429
6.73%
-0.0162
Schlusskurs vom Vortag:
$0.5591
Offen:
$0.55
24-Stunden-Volumen:
8,249
Relative Volume:
0.09
Marktkapitalisierung:
$3.01M
Einnahmen:
$832.80K
Nettoeinkommen (Verlust:
$-21.55M
KGV:
-0.0451
EPS:
-12.0465
Netto-Cashflow:
$-12.71M
1W Leistung:
-15.90%
1M Leistung:
-19.78%
6M Leistung:
-90.67%
1J Leistung:
-96.10%
1-Tages-Spanne:
$0.522
$0.55
1-Wochen-Bereich:
$0.4717
$0.638
52-Wochen-Spanne:
$0.4717
$17.80
Hcw Biologics Inc Stock (HCWB) Company Profile
Firmenname
Hcw Biologics Inc
Sektor
Branche
Telefon
954-842-2024
Adresse
2929 N COMMERCE PKWY, MIRAMAR
Compare HCWB vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
0.522 | 3.22M | 832.80K | -21.55M | -12.71M | -12.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.80 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.16 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
696.52 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.65 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.37 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Hcw Biologics Inc Aktie (HCWB) Neueste Nachrichten
Hedge Fund Moves: What is HCW Biologics Incs revenue forecastLayoff News & Low Risk Entry Point Tips - baoquankhu1.vn
AI Stocks: Will HCW Biologics Inc outperform tech stocksTrade Volume Report & Expert Curated Trade Ideas - baoquankhu1.vn
Buyout Rumor: Can HCW Biologics Inc stock double in the next yearWeekly Investment Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
AI Stocks: Is HCW Biologics Inc forming a breakout patternWeekly Gains Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
HCW Biologics (NASDAQ: HCWB) seeks warrant approvals at Apr 27 meeting - Stock Titan
HCWB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HCW Biologics regains compliance with all continued listing rules for Nasdaq per Nasdaq determination letter - marketscreener.com
HCW Biologics Regains Nasdaq Listing Compliance, Faces Ongoing Oversight - TipRanks
HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter - The Manila Times
HCW Biologics (NASDAQ: HCWB) back in full Nasdaq compliance - Stock Titan
HCW Biologics : February 2026 - marketscreener.com
EV Market: Is HCW Biologics Inc gaining market shareJuly 2025 Sector Moves & Stock Timing and Entry Methods - baoquankhu1.vn
EDGAR Filing Documents for 0000950170-24-127198 - SEC.gov
HCW Biologics Completes Follow-On Offering to Fund Pipeline - TipRanks
HCW Biologics Prices $1.5 Million Follow-On Offering of 2.48M Units at $0.6055 - TradingView
HCW Biologics Prices $1.5 Million Unit Offering - marketscreener.com
HCW Biologics lines up $1.5M, cuts warrant price to $0.6055 - Stock Titan
HCW Biologics Announces Follow-On Offering Pricing - Intellectia AI
HCW Biologics Inc. Announces Pricing of Follow-On Offering to Fund Immunotherapy Development - Quiver Quantitative
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - marketscreener.com
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - GlobeNewswire Inc.
Chipmakers Recap: Will HCW Biologics Inc outperform tech stocksJuly 2025 Update & Expert-Curated Trade Recommendations - baoquankhu1.vn
HCWB PE Ratio & Valuation, Is HCWB Overvalued - Intellectia AI
HCW Biologics Licenses TRBC Asset to China JV Trimmune - TipRanks
HCW Biologics enters $7 million licensing deal with China-based Trimmune - Investing.com Nigeria
HCW Biologics and WY Biotech announce closing of first round of financing for newly formed joint venture Trimmune - marketscreener.com
HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune - Investing News Network
Hcw Biologics And Wy Biotech Announce Closing Of First Round Of Financing For Newly Formed Joint Venture Trimmune - TradingView
Inside HCW Biologics’ $7M deal to test a new cancer drug in China - Stock Titan
Is HCW Biologics Inc. forming a breakout patternJuly 2025 Opening Moves & High Accuracy Swing Entry Alerts - mfd.ru
What is HCW Biologics Inc.’s book value per shareWeekly Investment Recap & Technical Pattern Based Buy Signals - mfd.ru
Downgrade Watch: How sensitive is HCW Biologics Inc to inflationFed Meeting & Weekly Setup with ROI Potential - baoquankhu1.vn
Market Leaders: Can HCW Biologics Inc. stock double in the next yearJuly 2025 PreEarnings & Low Volatility Stock Suggestions - baoquankhu1.vn
RSI Check: What is the earnings history of HCW Biologics IncJuly 2025 Earnings & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Risk Off: Can HCW Biologics Inc stock double in the next yearPortfolio Value Summary & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
HCW Biologics restructures obligations to regain Nasdaq compliance - MSN
US Stocks Recap: Is HCW Biologics Inc. forming a breakout patternJuly 2025 Highlights & Verified Momentum Watchlists - baoquankhu1.vn
Is HCW Biologics Inc. stock recession proofEarnings Recap Summary & Weekly Sector Rotation Insights - Улправда
How analysts rate HCW Biologics Inc. stock todayQuarterly Trade Summary & AI Enhanced Execution Alerts - ulpravda.ru
Will HCW Biologics Inc. stock attract ESG investorsJuly 2025 Spike Watch & Safe Capital Preservation Plans - Улправда
HCW Biologics Restructures Obligations to Regain Nasdaq Compliance - The Globe and Mail
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions - Investing.com Nigeria
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions By Investing.com - Investing.com South Africa
HCW Biologics Achieves Nasdaq Compliance Milestone - TradingView — Track All Markets
Returns Recap: Will HCW Biologics Inc stock attract ESG investorsEarnings Beat & Daily Price Action Insights - moha.gov.vn
HCW Biologics Granted Nasdaq Compliance Extension - MSN
Aug Analyst Calls: Is HCW Biologics Inc stock recession proofGDP Growth & AI Enhanced Trade Execution Alerts - Bộ Nội Vụ
US Market Recap: How analysts rate HCW Biologics Inc stock todayWeekly Investment Summary & Precise Buy Zone Identification - Bộ Nội Vụ
HCW Biologics (NASDAQ:HCWB) Shares Down 0.2% – Time to Sell? - Defense World
Reviewing HCW Biologics (NASDAQ:HCWB) and ImmunityBio (NASDAQ:IBRX) - Defense World
HCW Biologics Earnings Notes - Trefis
Finanzdaten der Hcw Biologics Inc-Aktie (HCWB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):